Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiri Minarik

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Molecular Medicine (Cambridge, Mass.)|November 29, 2025
Multi-hit TP53 confers the poorest survival in multiple myeloma in the era of novel therapiesRomana Nesnadna, Anna Petrackova, Jiri Minarik, et al.
Clinical Nuclear Medicine|August 14, 2010
Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patternsJaroslav Bacovsky, Miroslav Myslivecek, Vlastimil Scudla, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 9, 2010
The relationship between some soluble osteogenic markers, angiogenic cytokines/other biological parameters and the stages of multiple myeloma evaluated according to the Durie-Salmon and International Prognostic Index stratification systemsVlastimil Scudla, Tomas Pika, Marie Budikova, et al.
Clinical Case Reports|August 17, 2021
A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myelomaJiri Minarik, Tomas Szotkowski, Jan Hrbek, et al.
Leukemia Research|May 22, 2010
Combined measurement of plasma cell proliferative and apoptotic index in multiple myeloma defines patients with good and poor prognosisJiri Minarik, Vlastimil Scudla, Marta Ordeltova, et al.
Molecular Medicine Reports|June 26, 2026
Regulatory function of ten‑eleven translocation‑2 in transcriptional mechanisms of demethylated myeloma cellsLenka Slavickova, Michaela Nemcova, Dominika Svehlova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 17, 2008
The correlation of serum immunoglobulin free light chain levels and selected biological markers in multiple myelomaTomas Pika, Jiri Minarik, Petr Schneiderka, et al.
Journal of Translational Medicine|May 29, 2016
Centrosome associated genes pattern for risk sub-stratification in multiple myelomaFedor Kryukov, Pavel Nemec, Lenka Radova, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2016
Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/RelapseMiroslava Mlynarcikova, Jana Balcarkova, Pavla Mickova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 17, 2022
Global DNA methylation and increased DNMT3A expression in multiple myeloma patientsPetra Luzna, Denisa Weiser Drozdkova, Pavla Flodrova, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Molecular Medicine (Cambridge, Mass.)|November 29, 2025
Multi-hit TP53 confers the poorest survival in multiple myeloma in the era of novel therapiesRomana Nesnadna, Anna Petrackova, Jiri Minarik, et al.
Clinical Nuclear Medicine|August 14, 2010
Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patternsJaroslav Bacovsky, Miroslav Myslivecek, Vlastimil Scudla, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 9, 2010
The relationship between some soluble osteogenic markers, angiogenic cytokines/other biological parameters and the stages of multiple myeloma evaluated according to the Durie-Salmon and International Prognostic Index stratification systemsVlastimil Scudla, Tomas Pika, Marie Budikova, et al.
Clinical Case Reports|August 17, 2021
A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myelomaJiri Minarik, Tomas Szotkowski, Jan Hrbek, et al.
Leukemia Research|May 22, 2010
Combined measurement of plasma cell proliferative and apoptotic index in multiple myeloma defines patients with good and poor prognosisJiri Minarik, Vlastimil Scudla, Marta Ordeltova, et al.
Molecular Medicine Reports|June 26, 2026
Regulatory function of ten‑eleven translocation‑2 in transcriptional mechanisms of demethylated myeloma cellsLenka Slavickova, Michaela Nemcova, Dominika Svehlova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 17, 2008
The correlation of serum immunoglobulin free light chain levels and selected biological markers in multiple myelomaTomas Pika, Jiri Minarik, Petr Schneiderka, et al.
Journal of Translational Medicine|May 29, 2016
Centrosome associated genes pattern for risk sub-stratification in multiple myelomaFedor Kryukov, Pavel Nemec, Lenka Radova, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2016
Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/RelapseMiroslava Mlynarcikova, Jana Balcarkova, Pavla Mickova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 17, 2022
Global DNA methylation and increased DNMT3A expression in multiple myeloma patientsPetra Luzna, Denisa Weiser Drozdkova, Pavla Flodrova, et al.
Pageof 6